All In MedTech

Device Trial Radar · NCT06235450

A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation

Last checked: Nov 20, 2026Latest source record: Feb 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

200

Planned (sponsor's estimate)

Start

Jan 19, 2024

Primary completion

Dec 31, 2025

Study completion Dec 31, 2025

Sponsor

Lead sponsor
Olympic Ophthalmics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 1, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the usability of the iTEAR100 generation 2 device in combination with its newly developed iLIDS100 disposable cover.

Conditions

  • MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye Syndrome

Interventions

  • iLIDS100Device

    Subject applies iLIDS accessory to the iTEAR100 device. Applies to Eyelid margin similar to commercial products

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. QuestionnaireTime frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Olympic Ophthalmics

    Issaquah, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.